Last Updated on October 7, 2024 by The Health Master
Drug alert
Drug alert: Download the list of NSQ samples for August 2024, the link is given below: 59 drug samples declared as not of standard quality (NSQ), nationwide.
NSQ Lists are given below the article
Out of these 59 samples, 48 were declared NSQ by CDSCO and 11 were declared NSQ by various STATES across India.
Details of the NSQ samples declared by STATES is as under:
Sr. | Name of STATES | Number of NSQ samples declared |
1 | Kerala | 10 |
2 | J&K | 1 |
Total | 11 |
NOTE:
- NSQ data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Karnataka (PDF format), Thiruvanthapuram (Excel format), and Jammu Kashmir (Excel Format) for the Month of August, 2024 as per DCG(I) Circular dated 09.02.2024.
- State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Goa, Gujarat, Haryana, Himachal Pradesh, Manipur, Rajasthan, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry, Telangana, Delhi, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of August, 2024 as per DCG(I) Circular dated 09.02.2024.
Drug alert: Previous months
July 2024: 70 drug samples declared as NSQ, out of these 70 samples, 57 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
June 2024: 61 drug samples declared as NSQ, out of these 61 samples, 31 were declared NSQ by CDSCO and 30 were declared NSQ by various STATES across India.
May 2024: 52 drug samples declared as NSQ, out of these 52 samples, 39 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
April 2024: 50 drug samples declared as NSQ, out of these 50 samples, 33 were declared NSQ by CDSCO and 17 were declared NSQ by various STATES across India.
During the month of March 2024, the authorities tested 931 samples, out of which 864 were of standard quality. The number of samples declared as not of standard quality was 66, with one being misbranded and none being spurious.
During the month of February 2024, the authorities tested 1167 samples, out of which 1018 were of standard quality. The number of samples declared as not of standard quality was 58, with none being misbranded and two being spurious.
During the month of January 2024, the authorities tested 932 samples, out of which 886 were of standard quality. The number of samples declared as not of standard quality was 46, with none being misbranded and none being spurious.
During the month of December 2023, the authorities tested 1008 samples, out of which 930 were of standard quality. The number of samples declared as not of standard quality was 78, with none being misbranded and none being spurious.
During the month of November 2023, the authorities tested 1197 samples, out of which 1133 were of standard quality. The number of samples declared as not of standard quality was 62, with one being misbranded and one being spurious.
During the month of October 2023, the authorities tested 1105 samples, out of which 1044 were of standard quality. The number of samples declared as not of standard quality was 61, with none being misbranded and none being spurious.
During the month of September 2023, the authorities tested 1188 samples, out of which 1126 were of standard quality. The number of samples declared as not of standard quality was 62, with none being misbranded and none being spurious.
During the month of August 2023, the authorities tested 1166 samples, out of which 1118 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and none being spurious.
During the month of July 2023, the authorities tested 1306 samples, out of which 1252 were of standard quality. The number of samples declared as not of standard quality was 51, with none being misbranded and 3 being spurious.
The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, Indore, and Guwahati.
Drug alert: 70 drug samples declared as NSQ in July 2024
Drug alert: 61 drug samples declared as NSQ in June 2024
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Commercial Testing Laboratories
Latest Notifications: Testing Laboratories
Commercial Testing Laboratories
Commercial Testing Laboratories: Procedure
Updated list of Medical Device Testing Laboratories (MDTLs)
List of Laboratory Instruments for Pharma & Cosmetics Industry
Calibration of Laboratory Instruments
NABL: List of NABL Accredited Testing Laboratories
NABL 164 released : Guidelines for Inter-laboratory comparison
NABL releases NABL 136: specific criteria for X-Ray equipment
NABL 126: Specific criteria for calibration of Medical Devices
Laboratory Waste Management, Types and Its Disposal
NABL certification procedure for Laboratories
Quality Assurance Vs Quality Control in the Pharma Industry
NABL certification for Laboratories: Let’s understand
Major FDA audit findings about Equipment and Instruments
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
Cosmetics Testing in India: A Comprehensive Guide
Difference between Validation and Calibration in the Pharma Industry
Calibration of Laboratory Instruments
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Duties and responsibilities of QA person in Pharma Industry
Dissolution test: Importance in Pharma Industry
Licensing procedure for manufacturing of Drugs
Procedure to obtain license for manufacturing of Cosmetics
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Procedure to obtain license for manufacturing of Medical Devices
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Blood Centre (Blood Bank)
Procedure to obtain license for Commercial Testing Laboratories
PvPI and Adverse Drug Reaction: A Crucial Component of Pharmacy Education: Dr. B Suresh
DCC recommends closely monitoring quality of Eye Drops
Govt revises Guidelines, boosts Support for Pharma Industry
Maharashtra FDA cracks down on ayurvedic manufacturer DMROA
CDSCO Updates Guidance for Zonal, Sub-Zonal, and Port Offices
DCC recommends to address drug Brand Name Confusion in India
USFDA Inspection successfully completed at Indian firm Laurus Labs
List of Drugs declared as NSQ by CDSCO for the Month of August– 2024.
A. CDSCO/Central Laboratories | |||||||
S.No | Product/Drug Name | Batch No. | Manufacturing Date | Expiry Date | Manufactured By | NSQ Result | Reported by CDSCO Laboratory |
1. | Amoxicillin And Potassium Clavulanate Tablets IP (Clavam 625) | 23443940 | 11/2023 | 04/2025 | M/s. Alkem Health Science, Unit-2, Samardung, Karek Block, P.O. Namthang, South Sikkim 737 137. | Spurious Identification & Assay of Amoxycillin Trihydrate & Potassium Clavulanate | CDL, Kolkata |
2. | Amoxycillin & Potassium Clavulanate Tablets (Mexclav 625) | 7372 | 10/2023 | 09/2025 | M/s. Meg Lifesciences, Khasara No. 47/5, Palli Gaon, Distt-Sirmour- 173001. | Spurious Identification & Assay of Amoxycillin Trihydrate & Potassium Clavulanate | CDL, Kolkata |
3. | Calcium And Vitamin D3 Tablets IP Shelcal 500 (Shelcal) | GDXD0581 | 08/2023 | 07/2025 | M/s. Pure & Cure Healthcare Pvt. Ltd., Plot No. 26A, 27-30, Sector-8A, IIE, SIDCUL, Ranipur, Haridwar – 249 403, Uttarakhand. | Description, Identification of Vitamin D3, Dissolution of Calcium and Assay of Calcium & Vitamin D3 | CDL, Kolkata |
4. | Metformin Hydrochloride Sustained-release Tablets IP (Glycimet-SR-500) | GT3J023 | 10/2023 | 09/2025 | M/s. Scott-Edil Pharmacia Ltd., 56, EPIP, Phase-1, Jharmajri, Baddi, Distt. Solan -173205 (HP), India | Dissolution of Metformin Hydrochloride | CDL, Kolkata |
5. | Vitamin B Complex with Vitamin C Softgels | 1423 | 09/2023 | 08/2025 | M/s. Asoj Soft Caps Pvt. Ltd., Asoj, Baroda-Halol Highway, Dist-Baroda- 391510, GUJRAT | Assay of Calcium Pantothenate | CDL, Kolkata |
6. | Rifmin 550 (Rifaximin Tablets 550 mg) | TX-17798 | 02/2024 | 01/2026 | M/s. Legen Healthcare, Plot No. 20, Sector-5, Parwanoo, Distt. Solan (H.P.) 173220 | Dissolution & Water | CDL, Kolkata |
7. | Pantoprazole Gastro-Resistant and Domperidone Prolonged-Release Capsules IP (Pan – D) | 23444296 | 12/2023 | 11/2025 | M/s. Alkem Health Science, Unit-2, Samardung, Karek Block, P.O. Namthang, Dist. Namchi, Sikkim 737 137. | Spurious Identification, Assay, Dissolution & Related Substancces | CDL, Kolkata |
8. | Paracetamol Tablets IP 500 mg | 2508323 | 02/2023 | 01/2026 | M/s. Karnataka Antibiotics and Pharmaceuticals Ltd., Plot No. 14, II Phase, Peenya, Bengaluru-560058 | Description | CDL, Kolkata |
9. | Montair LC Kid (Montelukast Sodium & Levocetirizne Hydrochloride Dispersible Tablets) | AFB23W73 | 09/2023 | 08/2025 | M/s. Pure & Cure Healthcare Pvt. Ltd., Plot No. 26A, 27-30, Sector-8A, IIE, Sidcul, Ranipur, Haridwar 249 403, Uttarkhand | Uniformity of Dispersion & Assay of Montelukast Sodium | CDL, Kolkata |
10. | Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection) (RL 500 ml) | MP24050511 1 | 05/2024 | 04/2027 | M/s. Vision Parenteral Pvt. Ltd. Located at A-2, 44,45, Sector-15, GIDA, Sahjanwa (U.P.) 273 209 | Assay of Calcium Chloride | CDL, Kolkata |
11. | Fexofenadine Hydrochloride Tablets IP 120 mg | MP9AA2303 | 07/2023 | 06/2026 | M/s. Maxtar Bio-Genics, Khasra No-705, Vill-Malku Majra, Nalagarh Road, Baddi, Distt-Solan- 173205(HP), India | Dissolution | CDL, Kolkata |
12. | Fexofenadine Hydrochloride Tablets IP 120 mg | MP9AA2303 (Two different samples received with same batch number) | 07/2023 | 06/2026 | M/s. Maxtar Bio-Genics, Khasra No-705, Vill-Malku Majra, Nalagarh Road, Baddi, Distt-Solan- 173205(HP), India | Dissolution | CDL, Kolkata |
13. | Laxnorm Solution (Lactulose Solution USP) | LG24-0204 | 02/2024 | 01/2026 | M/s. Athens Life Sciences, Mauza Rampur Jattan, Nahan Road, Kala Amb, Dist-Sirmour, HP-173030 | Assay | CDL, Kolkata |
14. | Heparin Sodium Injection 5000 Units (Hostranil Injection) | HIHE23028A | 10/2023 | 09/2025 | M/s. Health Biotech Ltd., Village: Sandoli, Nalagarh Road, Baddi, Distt. Solan (H.P.), India-173205 | Particulate Matter, Bacterial Endotoxins & Sterility | CDL, Kolkata |
15. | Buflam Forte Suspension (Ibuprofen & Paracetamol Oral Suspension) | 231202A | 12/2023 | 11/2025 | M/s. Ornate Pharma Pvt. Ltd., 2, G.V.M.S.A.V Ltd., Odhav, Ahmedabad 382 410, Gujrat, India | Uniformity of Volume | CDL, Kolkata |
16. | Cepodem XP 50 Dry Suspension (Cefpodoxime Proxetil and Potassium Clavulanate Oral Suspension) | PEA0083 | 07/2023 | 12/2024 | M/s. Hetero Labs Limited (Unit-I), Village: Kalyanpur, Chakkan Road, Tehsil: Baddi, Dist: Solan, Himachal Pradesh – 173205. | pH and Assay of Potassium Clavulanate | CDL, Kolkata |
17. | Nimesulide, Paracetamol and Chlorzoxazone Tablets (NICIP MR) | GS22236 | 09/2022 | 08/2025 | M/s. HSN International Plot No. 54-55, Sector-6A, SIDCUL, Haridwar, (Uttarakhand) 249403 | Disintegration | CDL, Kolkata |
18. | Rolled Gauze (Non- Sterilized) | RG-006 | 01/2023 | 12/2024 | M/s. Blazon India, At: Musallahpur, Baripath, Patna-6 | Width, Absorbency, Scouring Loss, Freedom from Optical Whitener, Mass, Length | CDL, Kolkata |
19. | Ciprofloxacin Tablets I.P. 500 mg (Ocif-500) | OCF5-23- 221 | 05/2023 | 04/2025 | M/s. Ornate Labs Pvt. Ltd., Bela Industrial Estate, Muzaffarpur – 842 005 | Dissolution & Assay | CDL, Kolkata |
20. | Nimesulide, Phenylephrine Hydrochloride & Levocetirizine Dihydrochloride Tablets (Nunim- Cold) | T-23115 | 01/2023 | 12/2024 | M/s. Unispeed Pharmaceuticals Pvt. Ltd., 445/2, Behimd Wrigleys Vill. Katha, Baddi, Distt. Solan (H.P.) 173205 | Description | CDL, Kolkata |
21. | Adrenaline Injection I.P. Sterile 1 ml | AI22268 | 09/2022 | 08/2024 | M/s. Alves Healthcare Pvt. Ltd., Nangal Uperla, Swarghat Road, Nalagarh, Distt. Solan-174101 (HP). | Description, Appearance of Solution, Particulate Matter & Assay | CDL, Kolkata |
22. | Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection) RL 500ml | MP24040508 5 | 04/2024 | 03/2027 | M/s. Vision Parentral Pvt. Ltd., A-2-44-45, Sector 15, GIDA Industrial Area, Gorakhpur 273209 (U.P.), India. | Sterility | CDL, Kolkata |
23. | Vingel XL Pro Gel (Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate and Menthol Gel) | F23208 | 06/2023 | 05/2025 | M/s. Universal Twin Labs, Village Gullarwala, Near Sai Road, Baddi, District Solan, H.P. | Assay of Diclofenac Diethylamine & Methyl Salicylate | CDL, Kolkata |
24. | Atropine Sulphate Injection IP 2 ml | ATA12407 | 03/2024 | 02/2026 | M/s. Nandani Medical Laboratories Pvt. Ltd., 221/5, Bicholi Hapsi, Kanadia Road, Indore. | Description & Particulate Matter | CDL, Kolkata |
25. | Cefoperazone & Sulbactam For Injection (Todaycef 1.5 G) | D0481 | 11/2023 | 10/2025 | M/s. Daxin Pharmaceuticals Pvt. Ltd., Plot No. 121-122 EPIP, Jharmajri Phase-1, Teh. Baddi, Distt. Solan (H.P.) 174 103. | Clarity of Solution, Particulate matter and Assay | CDL, Kolkata |
26. | Heparin Sodium Injection IP 25000 IU / 5ml | GV3C002 | 03/2023 | 02/2026 | M/s. Scott-Edil Pharmacia Ltd., 56, E.P.I.P. Phase-1, Jharmajri, Baddi, Distt. Solan – 173 205 (H.P.), India | Description & Particulate Matter | CDL, Kolkata |
27. | Cefepime & Tazobactam for Injection (Crupime – TZ Kid Injection) | I230041A | 04/2023 | 03/2025 | M/s. Cosmas Research Lab. Ltd., Village: Gaunspura, P.O. Noorpur Bet, Hambran, Ludhiana 141 008 | Particulate Matter | CDL, Kolkata |
28. | Atropine Sulphate Injection I.P. (Atropine Sulphate) | AS-9055 (Two different samples received with same batch number) | 10/2022 | 09/2024 | M/s. Priya Pharmaceuticals 109/397, Nehru Nagar, Kanpur-208012, Uttar Pradesh | Description, pH, Particulate Matter, Extractable Volume | CDL, Kolkata |
29. | Atropine Sulphate Injection I.P. (Atropine Sulphate) | AS-9055 (Two different samples received with same batch number) | 10/2022 | 09/2024 | M/s. Priya Pharmaceuticals 109/397, Nehru Nagar, Kanpur-208012, Uttar Pradesh | Description, pH, Particulate Matter, Extractable Volume | CDL, Kolkata |
30. | Atropine Sulphate Injection I.P. (Atropine Sulphate) | AS-9057 (Two different samples received with same batch number) | 04/2023 | 03/2025 | M/s. Priya Pharmaceuticals 109/397, Nehru Nagar, Kanpur-208012, Uttar Pradesh | Description, Particulate Matter, Extractable Volume, Assay | CDL, Kolkata |
31. | Atropine Sulphate Injection I.P. (Atropine Sulphate) | AS-9057 (Two different samples received with same batch number) | 04/2023 | 03/2025 | M/s. Priya Pharmaceuticals 109/397, Nehru Nagar, Kanpur-208012, Uttar Pradesh | Description, Particulate Matter, Extractable Volume, Assay | CDL, Kolkata |
32. | Salbutamol, Bromhexine HCI, Guaifenesin and Menthol Syrup(Acozil Expectorant) | A-244003 | 04/2024 | 03/2027 | M/s. Antila Lifesciences Pvt Ltd, Plot No. P-2, Savli Bio- Tech Park, At-Manjusar, Tal-Savli, Dist- Vadodara- 391775, Gujarat, | Not of Standard Quality | CDTL-Mumbai |
33. | Diclofenac Sodium IP | DFS- 2405031 | 05/2024 | 04/2029 | M/s. Sara Exports Ltd. Plot No. 35, 35/1 & 36, South Side of GT Road, Industrial Area, Ghaziabad-201009 Uttar Pradesh, | Not of Standard Quality | CDTL-Mumbai |
34. | Escitalopram and Clonazepam Tablets IP (Klozaps-ES Tablets) | NTD0203 | 12/2023 | 11/2025 | M/.s Digital Vision, 176, Mauza Ogli, Nahan Road, Kala-Amb, Distt. Sirmour (H.P.)-173030 | Assay of Escitalopram Oxalate calculated as Escitalopram and Clonazepam | RDTL, Chandigarh |
35. | Phenytoin Sodium Injection USP | HIPY23012C | 10/2023 | 09/2025 | M/.s Health Biotech Ltd., Village Sandoli, Nalagarh Road, Baddi, Distt. Solan (H.P.) India-173205 | Alcohol, Propylene Glycol and Particulate Matter | RDTL, Chandigarh |
36. | Paracetamol, Phenylephrine Hydrochloride and Cetirizine Hydrochloride Suspension (Cethel Cold DS Suspension) | WPS-013 | 04/2024 | 03/2026 | M/s. Win Cure Pharma, Plot No. 21, DIC, Baddi (H.P.) 173205 | Assay of Paracetamol, Phenylephrine Hydrochloride and Cetirizine Hydrochloride | RDTL, Chandigarh |
37. | Calcium 500 mg with Vitamin D3 250 IU Tablets IP | LMT231058 | 12/2023 | 11/2025 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector 6A, IIE, SIDCUL, Haridwar249403 (U.K) | Assay of Calcium and vitamin D3 and Dissolution of Calcium | RDTL, Guwahati |
38. | Amoxycillin and Potassium Clavulanate Tablets IP 625 mg (Renamega- CV 625) | MD19AA08 | 10/2023 | 09/2025 | M/s. Malik Lifesciences Pvt. Ltd. (A Subsidiary of Akums Drugs & Pharmaceuticals Ltd.) Plot No. Vardhman, Indl. Estate, N.H.58, Haridwar-247667 (Uttarakhand) | Assay and Uniformity of content of Clavulanic Acid and Dissolution of Amoxycillin and Clavulanic Acid | RDTL, Guwahati |
39. | Olmesartan Medoxomil Tablets IP 40 mg | LMT240387 | 03/2024 | 02/2026 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector 6A, IIE, SIDCUL, Haridwar249403 (U.K) | Dissolution of Olmesartan Medoxomil | RDTL, Guwahati |
40. | INFUSION SET-NV | KT-015 | 01/2024 | 12/2026 | M/s. MEDIVISION HEALTHCARE, 84/4 Span Industrial Complex. Second Floor, Phase-1, ‘F’ Road, Opp. Kotak Mahindra Bank, G.I. D.C. Vatva, Ahmedabad- 382445 | Sterility | RDTL, Guwahati |
41. | Telmisartan Tablets IP 40 mg | LMT240528 | 05/2024 | 04/2026 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector 6A, IIE, SIDCUL, Haridwar249403 (U.K) | Description | RDTL, Guwahati |
42. | Telmisartan Tablets IP 40 mg | LMT240502 | 04/2024 | 03/2026 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector 6A, IIE, SIDCUL, Haridwar249403 (U.K) | Description | RDTL, Guwahati |
43. | Telmisartan Tablets IP 40 mg | LMT240502 | 04/2024 | 03/2026 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector 6A, IIE, SIDCUL, Haridwar249403 (U.K) | Description | RDTL, Guwahati |
44. | Telmisartan Tablets IP 40 mg | 251TTF011 | 07/2023 | 06/2025 | M/s. Swiss Garnier Life Science, 21-23, Industrial Area, Mehatpur, Dist. Una, , Himachal Pradesh- 174315. Iindia | Dissolution | RDTL, Guwahati |
45. | Alprazolam Tablets IP 0.25 mg (Erazol- 0.25 Tablets) | 16747 | 08/2023 | 07/2025 | M/s. ELIKEM Pharmaceuticals Private Limited, 816/1, Rakanpur, Ta. Kalol, Dist. Gandhinagar, Guj. 382721 | Dissolution | RDTL, Guwahati |
46. | GLIMEPIRIDE TABLETS IP (2 mg) | MT234799 | 11/2023 | 10/2025 | M/s, Mascot Health Series Pvt. Ltd., 79 & 80, Sec-6A, IIE Sidcul Haridwar- 249403 | Description | RDTL, Guwahati |
47. | Calcium and Vitamin D3 Tablets I.P. | UDT11151 | 08/2023 | 01/2025 | M/s. Unicure India Ltd., C- 21, 22 & 23, Sector-3, Noida-201 301 Distt. Gautam Budh Nagar (U.P.) | Assay of vitamin D3 | RDTL, Guwahati |
48. | Metronidazole Tablets IP 400mg | HMAA04 | 07/2023 | 06/2025 | M/s. HINDUSTAN ANTIBIOTICS LTD. (A Government of India Enterprises) at 11, W.E. A. Faridabad – 121001 (Haryana) R.O.:Pimpri, Pune-411018,INDIA | Dissolution | RDTL, Guwahati |
List of Drugs declared as NSQ by STATES for the Month of August– 2024.
B. State Laboratories |
S. No | Product/Drug Name | Batch No. | Manufacturing Date | Expiry Date | Manufactured By | NSQ Result | Reported by CDSCO Laboratory |
1. | Paziva -40 | GT300234 | 05/23 | 04-25 | M/s.Gnosis Pharmaceuticals Pvt.Ltd, Nahan Road , Village Moginand , Kala-Amb Dist. Sirmour, HP-173 030 | It fails the test ‘Dissolution’ as per IP | Drugs Testing Laboratory Thiruvananthapura m |
2. | Pantomed -40 | GTEO230 C | 01/24 | 12-25 | Digital Vision 176, Mauza ogli, Nahan Road, Kala -Amb, Dist Sirmour – 173 030 | It fails the test ‘Dissolution’ as per IP | Drugs Testing Laboratory Thiruvananthapura m |
3. | Cefixime Oral Suspension IP (Dry Syrup) | CADA-02 | 09 /23 | 08/25 | Nestor Pharmaceuticals Ltd, 11, Western Extension Area, Faridabad – 121001 | It fails the test ‘Assay’ and ‘water’ as per IP | Drugs Testing Laboratory Thiruvananthapura m |
4. | Moxymed CV | ABT 23316 | 11/23 | 04/25 | Alexa Pharmaceuticals , Plot No. 20, Ext HPSIDC, Indl.Area, Baddi, Solan – 173 205 | The content of Amoxycillin and Clavulanic acid is not with in the limits of schedule ‘V’ of Drugs and Cosmetics Act & Rules as mentioned in the Laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
5. | Frusemide Injection IP 20 mg | FRIB-03 | 01/24 | 12/25 | Nestor Pharmaceuticals Ltd, Faridabad- 121 001 | It fails the test ‘Sterility’ as per IP | Drugs Testing Laboratory Thiruvananthapura m |
6. | Kudajarishtam | 0110 | 01/24 | Nil | Bala Herbals, Industrial Estate, Edakkulangara, Kollam | It fails the tests ‘Total Solids’ and ‘Specific gravity’ as per API. | Drugs Testing Laboratory Thiruvananthapura m |
7. | Tab Nodosis | SMST- 24151 | 02/24 | 01/26 | Steadfast Medishield pvt.Ltd, At khasra,No.322, Nanhera , Anantpur, Bhgwanpur, Roorkee, Dist. Haridwar | It fails the test ‘Assay’ as per IP | Drugs Testing Laboratory Thiruvananthapura m |
8. | Haridrakhanda m | 207/23 | 03/24 | 02/26 | Bhaskara Vilasam Vaidyasala, Panayamuttom, Nedumangadu, Thiruvananthapuram – 695 561 | It fails the test ‘pH’ as per API. | Drugs Testing Laboratory Thiruvananthapura m |
9. | Pantoprazole Inj. BP 40 mg | D0726/24- 25 | Kerala Medical Services Corporation Ltd, Thycaud.P.O, Thiruvananthapuram | The sample does not comply with BP. It fails the test Particulate contaminatio n clarity and colour of solution. | Drugs Testing Laboratory Thiruvananthapura m | ||
10. | Yogaraja Guggulu | 209/21 | 03/22 | 3 yrs from mfg date | Bhaskara Vilasam Vaidyasala, Panayamuttom, Nedumangadu, Thiruvananthapuram – 695 561 | It fails the test Alcohol Soluble Extractive and pH as per API | Drugs Testing Laboratory Thiruvananthapura m |
11. | PANCEF-OF | T442401 | Jan-24 | Dec-25 | Aglomed Ltd. 51, Raipur , Roorkee – 247661 . H.O : 702-A, Poonam Chambers , Dr. A.B Road , Worli , Mumbai – 400018, India | The sample does not comply with respect to the test parameters at S.No II d (Disintegratio n Test) | Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024-25/978 Dated: 07.08.2024 |
NOTE:
- NSQ data was not received as per the format of DCG(I) Circular dated 09.02.2024 in EXCEL SHEET from State Drugs Licensing Authorities of Karnataka (PDF format), and Jharkhand (PDF format), for the Month of July, 2024.
- State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Goa, Gujarat, Haryana, Himachal Pradesh, Manipur, Rajasthan, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry, Telangana, Delhi, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of July, 2024 as per DCG(I) Circular dated 09.02.2024.
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: